Congratulations to our 2015 Celebration IsaBody Challenge Honorees!
These 10 IsaBody Challenge® Honorable Mentions successfully completed the IsaBody Challenge while motivating so many others along the way. Their success not only earned each of them an amazing physical transformation, but they also won $1,000 cash, and tickets, to an Isagenix event!
These inspirational individuals pushed hard for 16 weeks, and the results speak for themselves!
Here are the Honorable Mentions (listed in alphabetical order by first name):
Saint-Jean, Quebec
Age: 20
Height: 5’0”
Lost: 13 Pounds*
Number of Challenges: 4
Grand Rapids, Michigan
Age: 39
Height: 5’6”
Lost: 16 Pounds*
Number of Challenges: 4
Scottsdale, Arizona
Age: 42
Height: 6’0”
Lost: 13 Pounds*
Number of Challenges: 1
Brampton, Ontario
Age: 52
Height: 5’3”
Lost: 21 Pounds During the Challenge, 32 Pounds Total With Isagenix*
Number of Challenges: 1
Calgary, Alberta
Age: 53
Height: 5’8”
Lost: 5 Pounds*
Number of Challenges: 1
Newmarket, Ontario
Age: 34
Height: 5’8”
Lost: 1 Pound During the Challenge, 10 Pounds Total With Isagenix*
Number of Challenges: 4
North Conway, New Hampshire
Age: 33
Height: 6’1”
Lost: 32 Pounds*
Number of Challenges: 1
Cranbrook, British Columbia
Age: 31
Height: 5’4”
Gained: 5 Pounds*
Number of Challenges: 1
Calgary, Alberta
Age: 49
Height: 5’7”
Lost: 7 Pounds During the Challenge, 15 Pounds Total With Isagenix*
Number of Challenges: 3
Strathmore, Alberta
Age: 54
Height: 5’10”
Lost: 11 Pounds*
Number of Challenges: 1
Join these 10 amazing honorees and take charge of your body by completing the IsaBody Challenge!
*Weight loss should not be considered typical. In a study performed in 2012 by University of Illinois at Chicago researchers, subjects lost an average of 9 pounds after 30 days on an Isagenix System. The subjects also had a greater level of adherence and had more consistent weight loss from week to week compared to subjects on a traditional diet.
The post Top 10 Celebration 2015 IsaBody Challenge Honorees Unveiled appeared first on IsaFYI.
Related Stories
Source: Isogenix
